Abstract
Although hepatocellular carcinoma (HCC) is most often a sequela of severe hepatic fibrosis or cirrhosis, a proportion of cases arise in the noncirrhotic patient. The gold standard therapy in such cases is surgical resection. Innovations in operative technique allow for this treatment to be implemented with very low mortality and acceptable morbidity at high-volume hepatobiliary centers. This chapter discusses various etiologies of noncirrhotic HCC and presents a large single-center experience that is compared to other Western series.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AASLD:
-
American Association for the Study of Liver Diseases
- AFP:
-
Alpha-fetoprotein IVF, intravenous fluid
- ALT:
-
Alanine aminotransferase IOUS, intraoperative ultrasound
- AST:
-
Aspartate aminotransferase NAFLD, nonalcoholic fatty liver disease
- CVP:
-
Central venous pressure NASH, nonalcoholic steatohepatitis
- DM:
-
Diabetes mellitus OLT, orthotopic liver transplantation
- FLR:
-
Future liver remnant OS, overall survival
- FLV:
-
Future liver volume PPV, positive predictive value
- HCC:
-
Hepatocellular carcinoma PV, portal vein
- HBV:
-
Hepatitis B virus PVE, portal vein embolization
- HBsAg:
-
Hepatitis B surface antigen RFA, radiofrequency ablation
- HCV:
-
Hepatitis C virus RFS, recurrence-free survival
- HVE:
-
Hepatic vascular exclusion RR, relative risk
- HVPG:
-
Hepatic venous pressure gradient TACE, transarterial chemoembolization
- ICG:
-
Indocyanine green TLV, total liver volume
- IVC:
-
Inferior vena cava TTR, time to recurrence
References
Beasley RP, Hwang LY, Lin CC et al (1981) Hepatocellular carcinoma and hepatitis B virus: prospective study of 22,700 men in Taiwan. Lancet 2:1129–1133
Bege T, LeTruet YP, Hardwigsen J et al (2007) Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case series. J Gastrointest Surg 11:619–615
Bilimoria MM, Lauwers GY, Doherty DA et al (2001) Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 136:528–535
Bismuth H, Chiche L, Castaing D (1995) Surgical treatment of hepatocellular carcinoma in noncirrhotic liver: experience with 68 liver resections. World J Surg 19:35–41
Bralet MP, Regimbeau Pineau P et al (2000) Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 32:200–204
Chagas AL, Kikuchi LOO, Oliviera CPMS (2009) Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients? Braz J Med Biol Res 48:958–962
Chang CH, Chau GY, Lui WY et al (2004) Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 139:320–325
Chung YE, Park MS, Park YN et al (2009) Hepatocellular carcinoma variants: radiologic-pathologic correlation. Am J Roentgenol 193:W7–W13
Dupont-Bierre E, Compagnon P, Raoul JL et al (2005) Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg 201:663–670
El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 26(2):460–468
Farges O, Dokmak S (2010) Malignant transformation of liver adenoma: an analysis of the literature. Dig Surg 27:32–38
Fong Y, Sun RL, Jarnagin W et al (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790–800
Gassmann P, Spieker T, Haier J et al (2010) Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma. World J Surg 34:2442–2451
Grazi GL, Cescon M, Ravaioli M et al (2003) Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 17:119–129
Guzman G, Brunt EM, Petrovic LM et al (2008) Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch Pathol Lab Med 132:1761–1766
Kawada N, Imanaka K, Kawaguchi T et al (2009) Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 44:1190–1194
Lang H, Sotiropoulos GC, Brokalaki EI et al (2007) Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 205:27–36
Laurent C, Blanc JF, Nobili S et al (2005) Prognostic factors and longerm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 201:656–662
Leong TY, Leong AS (2005) Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB 7:5–15
Liu S, Chan KW, Wang B (2009) Fibrolamellar hepatocellular carcinoma. Am J Gastroenterol 104:2617–2624
Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312–1327
Lubrano J, Huet E, Basile T et al (2008) Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg 32:104–109
Madhoun MF, Fazili J, Bright BC et al (2010) Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci 339:169–173
McClune AC, Tong MJ (2010) Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis 14:461–476
Nash KL, Woodall T, Brown ASM et al (2010) Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis. World J Gastroenterol 16:4061–4065
Ohata K, Hamasaki K, Toriyama K et al (2003) Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97:3036–3043
Salomao M, Yu WM, Brown RS et al (2010) Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol 34:1630–1636
Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13:371–374
Sotiropoulos GC, Bockhorn M, Sgourakis G et al (2009) R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci 54:887–894
Starley BQ, Calcagno CJ, Harrison SA (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51:1820–1832
Trevasani F, Frigerio M, Santi V et al (2010) Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig and Liver Dis 42:341–347
Acknowledgments
The authors wish to acknowledge the invaluable contribution of Ghalib Jibara, M.D., M.P.H. in the preparation of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwartz, M.E., Shrager, B. (2013). Surgical Resection for Hepatocellular Carcinoma in the Noncirrhotic: The Western Experience. In: Vauthey, JN., Brouquet, A. (eds) Multidisciplinary Treatment of Hepatocellular Carcinoma. Recent Results in Cancer Research, vol 190. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16037-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-16037-0_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16036-3
Online ISBN: 978-3-642-16037-0
eBook Packages: MedicineMedicine (R0)